Xeroderma pigmentosum

MONDO:0019600

Xeroderma pigmentosum (XP) is a rare genodermatosis characterized by extreme sensitivity to ultraviolet (UV)-induced changes in the skin and eyes, and multiple skin cancers. It is subdivided into 8 complementation groups, according to the affected gene: classical XP (XPA to XPG) and XP variant (XPV).

Also known as: Kaposi dermatosis, Kaposi disease, XP, angioma pigmentosum atrophicum, atrophoderma pigmentosum, melanosis lenticularis progressiva, pigmented epitheliomatosis, xeroderma of Kaposi

9 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Xeroderma pigmentosum group F (1) Xeroderma pigmentosum variant type (1) Xeroderma pigmentosum, autosomal dominant, mild (0) Xeroderma pigmentosum, complementation group J (0) Xeroderma pigmentosum group A (0) Xeroderma pigmentosum group B (0) Xeroderma pigmentosum group C (0) Xeroderma pigmentosum group D (0) Xeroderma pigmentosum group E (0) Xeroderma pigmentosum group G (0)

Broader categories

Disease (680) Metabolic disease (233) Hereditary disease (176) Skin disorder (132) Inborn errors of metabolism (45) Human disease (14) DNA repair disease (13) Hereditary skin disorder (6) Disease of genetic or genomic mechanism (2) Disease by body system or component (0)

Trials to join now! 4 Not yet finished but already full! 2 Completed 2 Terminated 1

Could a gel cut down on skin cancer surgeries? new trial investigates

Disease control Terminated

This trial tests a gel called patidegib applied to the face twice daily for 9 months in people who develop many basal cell carcinomas (a common skin cancer) but do not have Gorlin syndrome. The goal is to see if the gel reduces the number of new skin cancers that would normally r…

Phase: PHASE2 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC

Xeroderma pigmentosum

Sub-types

Broader categories

Could a gel cut down on skin cancer surgeries? new trial investigates